Centenial Surgical Suture Ltd
Fri 4/09/2026,15:25:0 | BSE : CSURGSU
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 92.73
Previous Close
₹ 92.73
Volume
21
Mkt Cap ( ₹ Cr)
₹ 33.75
High
₹ 92.73
Low
₹ 92.50
52 Week High
₹ 124.90
52 Week Low
₹ 73.04
Book Value Per Share
₹ 75.40
Dividend Yield
₹ 0.00
Face Value
₹₹10.00
What's Your Call?
Collective community sentiment on Centenial Surgical Suture Ltd
Your Vote -
Buy
66.67%
Hold
0.00%
Sell
33.33%
66.67%
3 users have voted
Option Chain
Analyzes market sentiment, predicts Centenial Surgical Suture Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Centenial Surgic - Reg. 34 (1) Annual Report.
-
Centenial Surgic - Intimation Of AGM & Submission Of Notice Of 31St AGM To Be Held On Monday, September 28, 2026
-
Centenial Surgic - Price Of The Scrip Of Our Company Has Seen An Abnormal Price Rise
-
Centenial Surgic - Intimation Of 31St Annual General Meeting (AGM) Of The Company, Cut-Off Date For Voting And E-Voting As Pe
-
Centenial Surgic - Notice Of Book Closure As Per Regulation 42 Of The SEBI (Listing Obligations And Disclosures Requirements
-
Centenial Surgic - Re-Appointment Of Whole Time Director Of The Company - Regulation 30 Of The Securities And Exchange Board
-
Centenial Surgic - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
-
Centenial Surgic - Approval Of Standalone Un-Audited Financial Results For The Quarter Ended June 30, 2026
-
Centenial Surgic - Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday, August 14, 2026 Pursuant To Regulat
-
Centenial Surgic - Board Meeting Intimation for Approval Of Standalone Un-Audited Financial Results For The Quarter Ended Jun
-
Centenial Surgic has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026
-
Centenial Surgic - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Centenial Surgic - Announcement under Regulation 30 (LODR)-Change in Management
Key fundamentals
Evaluate the intrinsic value of Centenial Surgical Suture Ltd stockÂ
| Name | March-26 | March-25 | March-24 | March-23 | March-22 |
|---|---|---|---|---|---|
| Assets | 39.2593 | 43.0127 | 46.6626 | 40.9999 | 39.4961 |
| Liabilities | 39.2593 | 43.0127 | 46.6626 | 40.9999 | 39.4961 |
| Equity | 5.4243 | 5.4243 | 5.4243 | 5.4243 | 5.4243 |
| Gross Profit | 5.0892 | 6.2623 | 5.0037 | 4.2972 | 4.4485 |
| Net Profit | -2.2046 | -1.4636 | 1.1344 | 0.8859 | 0.6271 |
| Cash From Operating Activities | 3.9868 | 17.074 | 6.2147 | 1.2954 | 4.7509 |
| NPM(%) | -4.09 | -2.73 | 2.21 | 1.68 | 1.41 |
| Revenue | 53.8402 | 53.5162 | 51.1889 | 52.6553 | 44.4266 |
| Expenses | 48.751 | 47.2539 | 46.1852 | 48.3581 | 39.9781 |
| ROE(%) | -8.01 | -5.32 | 4.12 | 3.22 | 2.27 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Centenial Surgical Suture Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 863.00 | -0.52 | 21.76 | 52.79 | -26.19 | 0.58 |
| Lotus Eye Hospital and Institute Ltd | 109.90 | -0.68 | 1563.29 | 192.37 | 0.39 | 0.00 |
| Bharat Immunological and Biologicals Corporation Ltd | 15.42 | 0.72 | 0.00 | 399.41 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 552.30 | -3.93 | 0.00 | 206.11 | -363.14 | 0.00 |
Company Info
CENTINEIAL SURGICAL SUTURE LIMITED was incorporated as a Public Limited Company, on June 20, 1995 vide Certificate of Incorporation No. 11-89759 issued by the Registrar of Companies, Maharashtra at Bombay and received Certificate of Commencement of Business on July 5, 1995. The Company is setting up a project, at Vangani, Village Done, Taluka Ulhasnagar, Zilla Thane, Maharashtra, for manufacture 60 million ft. of absorbable surgical sterile sutures per annum. The project is appraised by SWIFT FINLEASE (INDIA) LIMITED, Bombay vide their appraisal note dated August 1, 1995. MAIN OBJECTS OF THE COMPANY The main objects of the Company as stated in the Memorandum of Association are as under: a. Main objects to be pursued on its incorporation are: 1. To carry on the business of manufacturing, trading, buying, developing, selling, distributing, importing, exporting, processing, canning, converting altering, refining, milling, preserving, packing, sterilization, dehydration, bottling and generally dealing in all types of surgical suture materials, micro sutures, absorbable and non absorbable, catgut, surgical linen thread, polyester synthetic, silk non-absorbable suture, raw silk filament, corrosion - resistant wires, mono filament, multi filament, braided silk, braided polyester, synthetic fibres, terylene, polyester-fibre plait, foil sachets, needles, double wrapped in foil sachets, sterile catgut plain, braided, coated, non absorbable, dispenser pack, reels, Polyamide Braided, Polyamide mono filament Polypropylene mono filament coated, braided polyester, surgical linen, virgin silk, sterilizing fluid stainless steel mono filament umbilical cotton tape, bone wax, polyester fibre tape, future dispenser, micro surgical cellulose swabs. SUBSIDIARY OF THE COMPANY The Company does not have any subsidiary. 2008 -The company has designated E-mail ID for Investors Complaints: admin@centenialindia.com.
CENTINEIAL SURGICAL SUTURE LIMITED was incorporated as a Public Limited Company, on June 20, 1995 vide Certificate of Incorporation No. 11-89759 issued by the Registrar of Companies, Maharashtra at Bombay and received Certificate of Commencement of Business on July 5, 1995. The Company is setting up a project, at Vangani, Village Done, Taluka Ulhasnagar, Zilla Thane, Maharashtra, for manufacture 60 million ft. of absorbable surgical sterile sutures per annum. The project is appraised by SWIFT FINLEASE (INDIA) LIMITED, Bombay vide their appraisal note dated August 1, 1995. MAIN OBJECTS OF THE COMPANY The main objects of the Company as stated in the Memorandum of Association are as under: a. Main objects to be pursued on its incorporation are: 1. To carry on the business of manufacturing, trading, buying, developing, selling, distributing, importing, exporting, processing, canning, converting altering, refining, milling, preserving, packing, sterilization, dehydration, bottling and generally dealing in all types of surgical suture materials, micro sutures, absorbable and non absorbable, catgut, surgical linen thread, polyester synthetic, silk non-absorbable suture, raw silk filament, corrosion - resistant wires, mono filament, multi filament, braided silk, braided polyester, synthetic fibres, terylene, polyester-fibre plait, foil sachets, needles, double wrapped in foil sachets, sterile catgut plain, braided, coated, non absorbable, dispenser pack, reels, Polyamide Braided, Polyamide mono filament Polypropylene mono filament coated, braided polyester, surgical linen, virgin silk, sterilizing fluid stainless steel mono filament umbilical cotton tape, bone wax, polyester fibre tape, future dispenser, micro surgical cellulose swabs. SUBSIDIARY OF THE COMPANY The Company does not have any subsidiary. 2008 -The company has designated E-mail ID for Investors Complaints: admin@centenialindia.com.
Read More
Parent Organisation
Centenial Surgical Suture Ltd.
Founded
20/06/1995
Managing Director
Mr.Vijay Majrekar
NSE Symbol
FAQ
The current price of Centenial Surgical Suture Ltd is
The 52-week high for Centenial Surgical Suture Ltd is
The market capitalization of Centenial Surgical Suture Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Centenial Surgical Suture Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Centenial Surgical Suture Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Centenial Surgical Suture Ltd shares.
The CEO of Centenial Surgical Suture Ltd is Mr.Vijay Majrekar, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.